Background / Objectives: Circadian light exposure and rest–activity timing may influence hematologic physiology through pathways involving autonomic regulation, inflammation, and vascular function. However, the relationships between objectively measured circadian exposures and platelet indices remain insufficiently characterized, particularly in young adults with previous SARS-CoV-2 infection. We investigated associations between actigraphy-derived light and activity metrics and platelet indices, and examined whether these associations differed according to previous infection status. Methods: One hundred twelve young adults (mean age 24.4±9.7 years; 74 COVID+, 38 COVID−) from Tyumen, Russia, wore wrist actigraphs with light sensors for 7 consecutive days (October–November 2023). Fasting morning complete blood counts provided platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT). Multivariable linear regression tested associations between circadian predictors and platelet indices, adjusted for age and sex. Results: No significant associations were found between circadian metrics and PLT, PDW, PCT, or MPV/PLT ratio after FDR correction. Higher MPV was independently associated with greater normalized amplitude of blue-light exposure, earlier BLE L5 onset, earlier wake time, and earlier 24-h activity acrophase. These associations were stronger in COVID+ participants and non-significant in COVID− participants. Earlier BLE L5 and fair light hygiene were associated with higher MPV in COVID+ only. Conclusions: In this cross-sectional study, MPV, but not the other platelet indices examined, was associated with selected measures of circadian light exposure and rest–activity timing. Associations were more pronounced among participants reporting previous SARS-CoV-2 infection. These findings identify a potential link between environmental circadian patterns and hematologic phenotype that warrants further investigation in relation to vascular physiology. Longitudinal studies incorporating direct measures of platelet function and cardiovascular regulation are needed to determine the underlying mechanisms and clinical significance.